Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel M Rubinstein

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of Clinical Investigation|April 15, 2011
Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in miceImmanuel Lerner, Esther Hermano, Eyal Zcharia, et al.
Cancer Research|September 5, 2019
Heparanase Accelerates Obesity-Associated Breast Cancer ProgressionEsther Hermano, Rachel Goldberg, Ariel M Rubinstein, et al.
Diabetes|November 23, 2011
Heparanase is essential for the development of diabetic nephropathy in miceNatali Gil, Rachel Goldberg, Tzahi Neuman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 4, 2025
Effective head and neck cancer treatment combines radiation and local extended cisplatin releaseNarmeen Daher-Ghanem, Shell Raveh, Awanish Kumar, et al.
NPJ Breast Cancer|May 29, 2021
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancerTamar Zahavi, Mali Salmon-Divon, Roberto Salgado, et al.
Genome Medicine|October 21, 2022
Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistanceHeba Alkhatib, Ariel M Rubinstein, Swetha Vasudevan, et al.
Molecular Cancer|January 16, 2024
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancerHeba Alkhatib, Jason Conage-Pough, Sangita Roy Chowdhury, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Clinical Investigation|April 15, 2011
Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in miceImmanuel Lerner, Esther Hermano, Eyal Zcharia, et al.
Cancer Research|September 5, 2019
Heparanase Accelerates Obesity-Associated Breast Cancer ProgressionEsther Hermano, Rachel Goldberg, Ariel M Rubinstein, et al.
Diabetes|November 23, 2011
Heparanase is essential for the development of diabetic nephropathy in miceNatali Gil, Rachel Goldberg, Tzahi Neuman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 4, 2025
Effective head and neck cancer treatment combines radiation and local extended cisplatin releaseNarmeen Daher-Ghanem, Shell Raveh, Awanish Kumar, et al.
NPJ Breast Cancer|May 29, 2021
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancerTamar Zahavi, Mali Salmon-Divon, Roberto Salgado, et al.
Genome Medicine|October 21, 2022
Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistanceHeba Alkhatib, Ariel M Rubinstein, Swetha Vasudevan, et al.
Molecular Cancer|January 16, 2024
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancerHeba Alkhatib, Jason Conage-Pough, Sangita Roy Chowdhury, et al.
Pageof 3